Memory Aging & Cognition Centre, National University Health System, Singapore.
Department of Pharmacology, National University of Singapore, Singapore.
J Alzheimers Dis. 2019;67(4):1209-1219. doi: 10.3233/JAD-180911.
Cerebral small vessel disease (SVD) is one of the major contributors to cognitive impairment and dementia. However, data on the incidence and progression of SVD in an Asian population are lacking.
The present study aims to investigate the incidence, progression, associated risk factors, and clinical relevance of SVD in a memory clinic setting.
A prospective case-control study, where 346 patients underwent repeated brain MRI with a mean interval of 24.5 months, accessing white matter hyperintensities (WMH), lacunes and cerebral microbleeds (CMBs). Severity of cognitive impairment was assessed using Clinical Dementia Rating scale and change in clinical diagnosis. Data on demographics, vascular risk factors, and clinical history were collected at baseline.
The prevalence of significant WMH (Fazekas ≥2) was 56.6% at baseline which progressed to 59.0% at follow-up. Overall prevalence of CMBs increased from 42.2% to 47.4% (9% new cases) and lacunes increased from 31.8% to 33.2% (2.1% new cases). Hypertension was associated with WMH progression (OR: 1.78, 95% CI: 1.01, 2.99) and increasing age was associated with incident CMBs (OR: 1.04, 95% CI: 1.01, 1.08). Moreover, the use of lipid-lowering medications decreased the incidence of lacunes (OR: 0.15, 95% CI: 0.04, 0.61). The major risk factor for incident SVD was baseline SVD lesion load. WMH progression was associated with increased severity of cognitive impairment (OR: 1.95, 95% CI: 1.16, 3.23).
Vascular risk factors and baseline severity of SVD lesion load were associated with progression of SVD. Furthermore, WMH progression was linked with increased severity of cognitive impairment. Future studies should be aimed to slow cognitive deterioration by preventing SVD related brain damage by targeting vascular risk factors.
脑小血管病(SVD)是认知障碍和痴呆的主要原因之一。然而,亚洲人群中 SVD 的发病率和进展情况的数据尚缺乏。
本研究旨在探讨在记忆诊所环境中 SVD 的发病率、进展、相关危险因素和临床相关性。
这是一项前瞻性病例对照研究,346 例患者接受了平均间隔 24.5 个月的重复脑部 MRI,评估脑白质高信号(WMH)、腔隙和脑微出血(CMB)。使用临床痴呆评定量表和临床诊断变化评估认知障碍严重程度。在基线时收集人口统计学、血管危险因素和临床病史数据。
基线时,有显著 WMH(Fazekas ≥2)的患者患病率为 56.6%,随访时上升至 59.0%。CMB 的总体患病率从 42.2%增加到 47.4%(9%新发病例),腔隙从 31.8%增加到 33.2%(2.1%新发病例)。高血压与 WMH 进展相关(OR:1.78,95%CI:1.01,2.99),年龄增长与新发 CMB 相关(OR:1.04,95%CI:1.01,1.08)。此外,降脂药物的使用降低了腔隙的发生率(OR:0.15,95%CI:0.04,0.61)。新发 SVD 的主要危险因素是基线 SVD 病变负荷。WMH 进展与认知障碍严重程度增加相关(OR:1.95,95%CI:1.16,3.23)。
血管危险因素和基线 SVD 病变负荷与 SVD 的进展相关。此外,WMH 进展与认知障碍严重程度增加相关。未来的研究应旨在通过针对血管危险因素来预防 SVD 相关脑损伤,从而减缓认知恶化。